Garret A. FitzGerald, MD, is the McNeil Professor in Translational Medicine and Therapeutics at the University of Pennsylvania in Philadelphia, where he chairs the Department of Pharmacology and directs the Institute for Translational Medicine and Therapeutics. Dr. FitzGerald’s research has contributed substantially to the development of low dose aspirin and was the first to predict and then mechanistically explain the cardiovascular hazard from NSAIDs. Dr. FitzGerald serves on the Council of Councils of the NIH and the Drug Forum of the Institute of Medicine.
info@goldlabfoundation.org
Garret A. FitzGerald, M.D.
Professor of Medicine and Pharmacology, McNeil Professor in Translational Medicine and Therapeutics, Chair Department of Pharmacology, Director, Institute for Translational Medicine & Therapeutics, Perelman School of Medicine, University of Pennsylvania
